Renaissance Technologies’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-330,900
| Closed | -$860K | – | 3710 |
|
|
2023
Q3 | $860K | Sell |
330,900
-327,800
| -50% | -$940K | ﹤0.01% | 2404 |
|
|
2023
Q2 | $2.33M | Buy |
658,700
+382,400
| +138% | +$1.72M | ﹤0.01% | 1898 |
|
|
2023
Q1 | $1.17M | Sell |
276,300
-231,700
| -46% | -$2.75M | ﹤0.01% | 2376 |
|
|
2022
Q4 | $8.36M | Sell |
508,000
-490,200
| -49% | -$5.51M | 0.01% | 1197 |
|
|
2022
Q3 | $12.7M | Buy |
998,200
+332,800
| +50% | +$4.91M | 0.02% | 897 |
|
|
2022
Q2 | $7.79M | Buy |
665,400
+276,700
| +71% | +$1.71M | 0.01% | 1250 |
|
|
2022
Q1 | $2.37M | Buy |
388,700
+321,900
| +482% | +$2.37M | ﹤0.01% | 2115 |
|
|
2021
Q4 | $612K | Buy |
+66,800
| New | +$710K | ﹤0.01% | 2981 |
|
|
2020
Q4 | – | Sell |
-1,024,507
| Closed | -$13.5M | – | 3358 |
|
|
2020
Q3 | $13.5M | Buy |
1,024,507
+98,800
| +11% | +$1.98M | 0.01% | 958 |
|
|
2020
Q2 | $9.91M | Buy |
925,707
+308,700
| +50% | +$1.7M | 0.01% | 1230 |
|
|
2020
Q1 | $1.98M | Buy |
617,007
+443,656
| +256% | +$1.02M | ﹤0.01% | 2054 |
|
|
2019
Q4 | $328K | Buy |
173,351
+129,736
| +297% | +$240K | ﹤0.01% | 3047 |
|
|
2019
Q3 | $85K | Buy |
+43,615
| New | +$96.7K | ﹤0.01% | 3277 |
|
|
2019
Q2 | – | Sell |
-109,306
| Closed | -$317K | – | 3524 |
|
|
2019
Q1 | $317K | Sell |
109,306
-85,200
| -44% | -$254K | ﹤0.01% | 3071 |
|
|
2018
Q4 | $401K | Buy |
194,506
+152,205
| +360% | +$539K | ﹤0.01% | 2936 |
|
|
2018
Q3 | $186K | Buy |
42,301
+16,436
| +64% | +$179K | ﹤0.01% | 3165 |
|
|
2018
Q2 | $345K | Buy |
25,865
+11,446
| +79% | +$225K | ﹤0.01% | 2933 |
|
|
2018
Q1 | $502K | Sell |
14,419
-6,535
| -31% | -$328K | ﹤0.01% | 2912 |
|
|
2017
Q4 | $1.25M | Sell |
20,954
-471
| -2% | -$30.1K | ﹤0.01% | 2580 |
|
|
2017
Q3 | $1.49M | Sell |
21,425
-649
| -3% | -$48.3K | ﹤0.01% | 2418 |
|
|
2017
Q2 | $2.12M | Buy |
22,074
+6,104
| +38% | +$1.01M | ﹤0.01% | 2233 |
|
|
2017
Q1 | $3.89M | Buy |
15,970
+4,813
| +43% | +$2.57M | 0.01% | 1844 |
|
|
2016
Q4 | $10.9M | Buy |
11,157
+9,443
| +551% | +$8.46M | 0.02% | 1169 |
|
|
2016
Q3 | $1.49M | Buy |
1,714
+1,217
| +245% | +$955K | ﹤0.01% | 2370 |
|
|
2016
Q2 | $364K | Buy |
+497
| New | +$340K | ﹤0.01% | 2888 |
|
|
2014
Q2 | – | Sell |
-72
| Closed | -$40K | – | 2764 |
|
|
2014
Q1 | $40K | Sell |
72
-63
| -47% | -$36.8K | ﹤0.01% | 2766 |
|
|
2013
Q4 | $75K | Sell |
135
-353
| -72% | -$211K | ﹤0.01% | 2759 |
|
|
2013
Q3 | $307K | Buy |
+488
| New | +$280K | ﹤0.01% | 2463 |
|
Other funds holding ALT
TCM
N
TIM
Renaissance Technologies's ALT Position: Q4 2023 in Review
Renaissance Technologies sold out of Altimmune (ALT) in Q4 2023, closing a stake of 330,900 shares — an estimated $860K sold.
Renaissance Technologies first reported a position in ALT in Q3 2013 and held it in 28 quarters. The position peaked at $13.5M in Q3 2020. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.
- Renaissance Technologies reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
- Renaissance Technologies sold 330,900 Altimmune shares in Q4 2023, an estimated $860K.
- Renaissance Technologies first reported a position in Altimmune in Q3 2013 and held it in 28 quarters.
- Renaissance Technologies's Altimmune position peaked at $13.5M in Q3 2020.
- 143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.